Oral Liquid Topiramate
Medication Transformed
The ONLY ready-to-use oral liquid solution approved by the US Food & Drug Administration (FDA) for the treatment of epilepsy, Lennox-Gastaut syndrome (LGS), and migraine.
Eligible patients may pay as little as $0 co-pay* for their first prescription and associated refills.
*View Eligibility Restrictions, Terms, and Conditions at azuritysolutions.com.
Please see Important Safety Information below.
Azurity's $25 Donation: Support Epilepsy and Migraine Communities!
Azurity Pharmaceuticals is thrilled to support the work of the epilepsy and migraine communities and to have the opportunity to help patients and their families! Select a support or advocacy organization from the list here and Azurity will make a $25 donation to its cause. Thank you for joining us with your support!
The beyond-use date of EPRONTIA® is 90 days after a bottle is first opened.
EPRONTIA® (topiramate) oral solution is for the treatment* of:
- Epilepsy:
- Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. (Monotherapy is the use of a single medication to treat epilepsy.)
- Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. (Adjunctive therapy is taken in addition to other epilepsy medications.)
- Migraine:
- Preventive treatment of migraine in patients 12 years of age and older. (Preventive treatment is given to help stop a migraine before it starts.)
*A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Once opened, unused portion should be discarded after 90 days.
Topiramate was first approved in the United States in 1996 to treat epilepsy and Lennox-Gastaut Syndrome (LGS), and in 2004 for the prevention of migraine.1
EPRONTIA® is the only ready-to-use oral liquid topiramate.
Ready-to-use means no need for:
- compounding
- crushing or mixing
-
Mixed-berry flavor
May help enhance the taste
-
Ready-to-use
No shaking needed, no preparation required Throw away any unused medication 90 days after opening
-
Widely available
Accessible at most pharmacies within 24 hours
-
Flexible dosing
So you can get the right dose your doctor prescribes, every time
Talk to your doctor to see if EPRONTIA® may be right for you.
Learn more about starting your journey with EPRONTIA®
Download Patient BrochureMeet Ginger and Makayla
Eligible patients may pay as little as $0 co-pay*
for their first prescription and associated refills
- Eligible patients can save with automatic co-pay support for EPRONTIA® at their pharmacy—no calls, cards, or coupons necessary
- Instant co-pay savings at 70,000+ pharmacies
*View Eligibility Restrictions, Terms, and Conditions at azuritysolutions.com.
Prescription coverage doesn’t have to be complicated.
For answers to your questions about EPRONTIA® coverage, visit azuritysolutions.com.
Learn more about EPRONTIA®Find a Doctor
Search for a physician by name, location, or specialty.
Find a Doctor for Epilepsy Care
SearchBy clicking Submit, you agree to disclose your personal information to Azurity and to be contacted by Azurity, its affiliates,
and business partners in the future regarding products, services, and/or information related to EPRONTIA®. Azurity will not
sell your information to any third party for marketing purposes without your express consent.
Resources
Below are organizations that may be able to support you and your family.
CURE Epilepsy
The leading nongovernmental agency fully committed to funding research in epilepsy, CURE Epilepsy promotes and funds patient-focused research, and makes information available to clinicians and patients.
Learn more about CURE EpilepsyEpilepsy Alliance America
This nationwide network of community-based epilepsy organizations provides direct support to people with epilepsy, their families, caregivers, and communities through support services, information, education, advocacy, and public awareness.
Learn more about Epilepsy Alliance AmericaNational Headache Foundation
For over 50 years, this non-profit foundation has worked to increase awareness of headache and migraine. Their focus is on advocacy for people living with headache disorders, education for patients and healthcare providers, and supporting research to find a cure.
Learn More about National Headache FoundationLGS Foundation
The Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS through advancing research, awareness, education, and family support.
Learn More about LGS FoundationNational Association of Epilepsy Centers
This non-profit association of more than 260 specialized epilepsy centers in the United States educates public and private insurers, policymakers, and government officials about the complexities of and need for patient access to specialized epilepsy services.
Learn More about National Association of Epilepsy Centers